SEC Filings

Filing date	Form	Description	View
02/27/18	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-18-012808.pdf 0001104659-18-012808.rtf 0001104659-18-012808.xls
02/22/18	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-18-002607.pdf 0001179110-18-002607.rtf 0001179110-18-002607.xls
02/22/18	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-18-002606.pdf 0001179110-18-002606.rtf 0001179110-18-002606.xls
02/22/18	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-18-002614.pdf 0001179110-18-002614.rtf 0001179110-18-002614.xls
02/22/18	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-18-002610.pdf 0001179110-18-002610.rtf 0001179110-18-002610.xls
02/22/18	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-18-002612.pdf 0001179110-18-002612.rtf 0001179110-18-002612.xls
02/22/18	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-18-002608.pdf 0001179110-18-002608.rtf 0001179110-18-002608.xls
02/22/18	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-18-002613.pdf 0001179110-18-002613.rtf 0001179110-18-002613.xls
02/22/18	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-18-002611.pdf 0001179110-18-002611.rtf 0001179110-18-002611.xls
02/22/18	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-18-002615.pdf 0001179110-18-002615.rtf 0001179110-18-002615.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.